CAPRICOR THERAPEUTICS, INC.
CAPR · Pharmaceutical Preparations · 57.9M shares · +23%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: -$7M (gross $193, SBC $7M)
Reference price $30.00 · est. market cap ~$1.7B — last insider sale, 2026-06-24 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D44Clinical/early-stage biotech — DMD biotech, well-funded after a CRL setback.
Strengths
- Liquidity — current ratio 9.0 (76th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Cash burnNegative free cash flow (-72.7M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Strong balance sheetStrong balance sheet — $318M cash & investments, ~18 quarters of runway
- Notable holderHeld by 4 notable fund(s): STATE STREET CORP, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC +1 more (as of 2026-03-31)
- Insider sellingInsider selling — 11 open-market sale(s) by 3 insider(s) (cluster of 3 insiders, ~$7M, last 6mo) Form 4 ↗
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-34.4%
Return on assets
-29.5%
Revenue growth (QoQ)
392.1%
Current ratio
9.0×
Free cash flow
-$73M
EBITDA
-$106M
Tangible book value
$306M
Cash & investments
$318M
Cash runway
18q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-24 | Bergmann Anthony | Option exercise | 400 | $3.18 |
| 2026-06-24 | Bergmann Anthony | Sell | 400 | $30.00 |
| 2026-06-24 | Krasney Karen | Option exercise | 400 | $3.18 |
| 2026-06-24 | Krasney Karen | Sell | 400 | $30.00 |
| 2026-06-22 | Krasney Karen | Option exercise | 500 | $3.18 |
| 2026-06-22 | Bergmann Anthony | Sell | 500 | $30.00 |
| 2026-06-22 | Bergmann Anthony | Option exercise | 500 | $3.18 |
| 2026-06-22 | Krasney Karen | Sell | 500 | $30.00 |
| 2026-05-18 | Bergmann Anthony | Option exercise | 3.0K | $1.39 |
| 2026-05-13 | Litvack Frank | Option exercise | 3.9K | $1.39 |
| 2026-05-01 | Bergmann Anthony | Option exercise | 25K | $3.18 |
| 2026-05-01 | Bergmann Anthony | Sell | 25K | $31.70 |
| 2026-05-01 | Krasney Karen | Option exercise | 25K | $3.18 |
| 2026-05-01 | Krasney Karen | Sell | 25K | $31.70 |
| 2026-04-02 | Sabar Karimah Es | Option exercise | 7.5K | $3.18 |
| 2026-04-02 | Sabar Karimah Es | Sell | 7.5K | $32.00 |
| 2026-04-01 | Sabar Karimah Es | Option exercise | 54K | $4.86 |
| 2026-04-01 | Sabar Karimah Es | Sell | 54K | $31.03 |
| 2026-03-31 | Sabar Karimah Es | Option exercise | 61K | $4.86 |
| 2026-03-31 | Bergmann Anthony | Option exercise | 25K | $3.18 |
| 2026-03-31 | Bergmann Anthony | Sell | 25K | $30.13 |
| 2026-03-31 | Krasney Karen | Option exercise | 693 | $1.39 |
| 2026-03-31 | Krasney Karen | Option exercise | 21K | $3.74 |
| 2026-03-31 | Krasney Karen | Option exercise | 2.8K | $3.18 |
| 2026-03-31 | Krasney Karen | Sell | 25K | $30.12 |
| 2026-03-31 | Sabar Karimah Es | Sell | 61K | $30.17 |
| 2025-12-30 | Krasney Karen | Option exercise | 2.5K | $1.39 |
| 2025-12-19 | DUNBAR GEORGE W JR | Option exercise | 3.0K | $1.39 |
| 2025-03-05 | Marban Linda | Other | 12K | — |
| 2025-03-03 | Litvack Frank | Option exercise | 25K | $1.39 |
| 2025-03-03 | Marban Linda | Option exercise | 25K | $1.39 |
| 2025-03-03 | DUNBAR GEORGE W JR | Option exercise | 750 | $1.39 |
| 2025-03-03 | Bergmann Anthony | Option exercise | 2.5K | $1.39 |
| 2025-03-03 | Litvack Frank | Tax withheld | 2.5K | $13.67 |
| 2025-02-27 | COLLIER EARL M JR | Option exercise | 750 | $1.39 |
| 2025-01-02 | Bergmann Anthony | Grant | 3.3K | — |
All non-derivative Form 4 activity (SEC), newest first.
Supply chain
Customers (1)
- Nippon Shinyaku
Suppliers (6)
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Johns Hopkins University
- U.S. Department of Defense (DoD)
- U.S. Army Institute of Surgical Research (USAISR)
- Cedars-Sinai Medical Center
Named in the 10-K; linked when we track them.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-26 | 0001104659-26-078327 ↗ |
| 8-K | 2026-06-08 | 2026-06-04 | 0001104659-26-071364 ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | 0001104659-26-060382 ↗ |
| 8-K | 2026-05-12 | 2026-05-12 | 0001104659-26-059380 ↗ |
| 8-K | 2026-05-07 | 2026-05-07 | 0001104659-26-057221 ↗ |
| 10-K | 2026-03-17 | 2025-12-31 | 0001104659-26-029580 ↗ |
| 8-K | 2026-03-12 | 2026-03-12 | 0001104659-26-027037 ↗ |
| 8-K | 2026-03-10 | 2026-03-10 | 0001104659-26-025657 ↗ |
| 8-K | 2025-12-05 | 2025-12-05 | 0001104659-25-118934 ↗ |
| 8-K | 2025-12-03 | 2025-12-03 | 0001104659-25-117981 ↗ |
| 8-K | 2025-12-03 | 2025-12-03 | 0001104659-25-117947 ↗ |
| 10-Q | 2025-11-10 | 2025-09-30 | 0001104659-25-109298 ↗ |